| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |